Nkarta, Inc. Investment Income, Net
Nkarta, Inc. (NKTX) reported Investment Income, Net of $2.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-10
- Nkarta, Inc. investment income, net for the quarter ending 2026-06-30 was $2.54M, a 36.07% decline year-over-year.
- Nkarta, Inc. investment income, net for the quarter ending 2026-03-31 was $2.84M, a 35.15% decline year-over-year.
- Nkarta, Inc. investment income, net for the quarter ending 2025-12-31 was $3.30M, a 32.65% decline year-over-year.
- Nkarta, Inc. investment income, net for the quarter ending 2025-09-30 was $3.85M, a 29.36% decline year-over-year.
- Nkarta, Inc. investment income, net for fiscal 2025 was $15.49M, a 19.79% decline from fiscal 2024.
- Nkarta, Inc. investment income, net for fiscal 2024 was $19.32M, a 36.93% increase from fiscal 2023.
- Nkarta, Inc. investment income, net for fiscal 2023 was $14.11M, a 152.45% increase from fiscal 2022.
- Nkarta, Inc. investment income, net for fiscal 2022 was $5.59M, a 1410.27% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.54M 10-Q · filed 2026-08-10 | $5.38M 10-Q · filed 2026-08-10 | $8.67M derived: sum of 3 quarters · filed 2026-08-10 | $12.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.84M 10-Q · filed 2026-05-12 | $6.13M derived: sum of 2 quarters · filed 2026-05-12 | $9.99M derived: sum of 3 quarters · filed 2026-05-12 | $13.96M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $7.15M derived: sum of 2 quarters · filed 2026-03-25 | $11.12M derived: sum of 3 quarters · filed 2026-08-10 | $15.49M 10-K · filed 2026-03-25 |
| 2025-09-30 | $3.85M 10-Q · filed 2025-11-10 | $7.82M derived: sum of 2 quarters · filed 2026-08-10 | $12.20M 10-Q · filed 2025-11-10 | $17.09M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $3.97M 10-Q · filed 2026-08-10 | $8.35M 10-Q · filed 2026-08-10 | $13.24M derived: sum of 3 quarters · filed 2026-08-10 | $18.69M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $4.38M 10-Q · filed 2026-05-12 | $9.27M derived: sum of 2 quarters · filed 2026-05-12 | $14.72M derived: sum of 3 quarters · filed 2026-05-12 | $20.45M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $10.35M derived: sum of 2 quarters · filed 2026-03-25 | $16.07M derived: sum of 3 quarters · filed 2026-03-25 | $19.32M 10-K · filed 2026-03-25 |
| 2024-09-30 | $5.45M 10-Q · filed 2025-11-10 | $11.18M derived: sum of 2 quarters · filed 2025-11-10 | $14.42M 10-Q · filed 2025-11-10 | $17.88M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $5.72M 10-Q · filed 2025-08-12 | $8.97M 10-Q · filed 2025-08-12 | $12.43M derived: sum of 3 quarters · filed 2025-08-12 | $16.04M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-14 | $6.70M derived: sum of 2 quarters · filed 2025-05-14 | $10.32M derived: sum of 3 quarters · filed 2025-05-14 | $13.89M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $7.07M derived: sum of 2 quarters · filed 2025-03-26 | $10.64M derived: sum of 3 quarters · filed 2025-03-26 | $14.11M 10-K · filed 2025-03-26 |
| 2023-09-30 | $3.62M 10-Q · filed 2024-11-07 | $7.19M derived: sum of 2 quarters · filed 2024-11-07 | $10.65M 10-Q · filed 2024-11-07 | $13.54M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.57M 10-Q · filed 2024-08-13 | $7.04M 10-Q · filed 2024-08-13 | $9.93M derived: sum of 3 quarters · filed 2024-08-13 | $11.82M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $3.46M 10-Q · filed 2024-05-09 | $6.36M derived: sum of 2 quarters · filed 2024-05-09 | $8.26M derived: sum of 3 quarters · filed 2024-05-09 | $8.94M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $4.79M derived: sum of 2 quarters · filed 2024-03-21 | $5.48M derived: sum of 3 quarters · filed 2024-03-21 | $5.59M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.90M 10-Q · filed 2023-11-09 | $2.59M derived: sum of 2 quarters · filed 2023-11-09 | $2.70M 10-Q · filed 2023-11-09 | $2.77M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $686.00K 10-Q · filed 2023-08-10 | $798.00K 10-Q · filed 2023-08-10 | $873.00K derived: sum of 3 quarters · filed 2023-08-10 | $954.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $112.00K 10-Q · filed 2023-05-11 | $187.00K derived: sum of 2 quarters · filed 2023-05-11 | $268.00K derived: sum of 3 quarters · filed 2023-05-11 | $372.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $156.00K derived: sum of 2 quarters · filed 2023-03-16 | $260.00K derived: sum of 3 quarters · filed 2023-03-16 | $370.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $81.00K 10-Q · filed 2022-11-09 | $185.00K derived: sum of 2 quarters · filed 2022-11-09 | $295.00K 10-Q · filed 2022-11-09 | $250.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $104.00K 10-Q · filed 2022-08-11 | $214.00K 10-Q · filed 2022-08-11 | $169.00K derived: sum of 3 quarters · filed 2022-08-11 | $375.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $110.00K 10-Q · filed 2022-05-12 | $65.00K derived: sum of 2 quarters · filed 2022-05-12 | $271.00K derived: sum of 3 quarters · filed 2022-05-12 | $298.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $161.00K derived: sum of 2 quarters · filed 2022-03-17 | $188.00K derived: sum of 3 quarters · filed 2022-03-17 | $313.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $206.00K 10-Q · filed 2021-11-10 | $233.00K derived: sum of 2 quarters · filed 2021-11-10 | $358.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $27.00K 10-Q · filed 2021-08-12 | $152.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $124.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $304.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |